Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$14.30 USD
-0.01 (-0.07%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $14.28 -0.02 (-0.14%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
XRAY 14.30 -0.01(-0.07%)
Will XRAY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for XRAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XRAY
Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Align Technology (ALGN) Q2 Earnings and Revenues Lag Estimates
XRAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Dentsply International (XRAY) is a Strong Momentum Stock
Here's Why Dentsply International (XRAY) is a Strong Value Stock
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Other News for XRAY
Heartland Small Cap Value Strategy Q2 2025 Commentary
Dentsply Sirona (XRAY) Stock Outlook: Analyst Maintains Outperform Rating | XRAY Stock News
Needham Reiterates Hold Rating on Dentsply Sirona (XRAY) | XRAY Stock News
Roth bullish on Globus Medical amid CEO Transition, solid pre-reported results
Dentsply Sirona (XRAY) Appoints New CEO, Reaffirms 2025 Outlook